Hemodynamic parameters in a surgical devascularization model of fulminant hepatic failure in the minipig

Physiological Research

Volumn 54, Issue 5, 2005, Pages 485-490

  Kieslichova E ^a   Ryska, M ^a   Pantoflicek T ^a   Ryska, O ^a   Zazula, R ^a   Skibova J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Devascularization surgical pig model; Fulminant acute hepatic failure; Hemodynamic parameters

Indexed keywords

NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VOLUME; COLLOID; CONTINUOUS INFUSION; CONTROLLED STUDY; CRYSTALLOID; DEVASCULARIZATION; EXPERIMENTAL MODEL; HEART RATE; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; LIVER FAILURE; LUNG VENTILATION; MEAN ARTERIAL PRESSURE; NONHUMAN; SURVIVAL; SWINE; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; HEART RATE; HEPATIC ARTERY; LIVER FAILURE, ACUTE; REFERENCE VALUES; SWINE; SWINE, MINIATURE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 27644580335     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ABRAHAMSE SL, VAN DE KERKHOVE MP, SOSEF MN, HARTMAN R, CHAMULEAU RA, VAN GULIK TM: Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system. Int J Artif Organs. 25: 966-974, 2002.
2. BERNSTEIN D, TRIPODI J: Fulminant hepatic failure. Crit Care Clin 14: 181-197, 1998.
3. BERNUAU J, RUEFF B, BERNHAMOU JP: Fulminant and subfulminant liver failure. Definitions and causes. Semin Liver Dis 6: 97-106, 1986.
4. BILHARI D, WENDON J: Tissue hypoxia in fulminant hepatic failure. In: Acute Liver Failure: Improved Understanding and Better Therapy. WILIAMS R, HUGHES RD (eds), Miter Press, London, 1991, pp 42-44.
5. BILHARI D, GIMSON AE, WATERSON M, WILIAMS R: Tissue hypoxia during fulminant hepatic failure. Crit Care Med 13: 1034-1039, 1985.
6. BILHARI D, GIMSON AES, WILIAMS R: Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis 6: 119-128, 1986.
7. BLEI AT: Brain edema and intracranial hypertension: A focus for the use of liver support systems. Artif Organs 22: 26, 1998.
8. DE GROOT GH, REUVERS CB, SCHAIM SW: A reproducible model of acute hepatic failure by transient ischemia in the pig. J Surg Res: 42: 92-100, 1987.
9. ELLIS A, WENDON J: Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 16: 379, 1996.
10. GILL RQ, STERLING RK: Acute liver failure. J Clin Gastroenterol 33: 191-198, 2001.
11. HANNING CD: Cardiovascular physiology. Cardiovascular response to disease and anaesthesia. In: Textbook of Anaesthesia. AR AITKINHEAD, G SMITH (eds), Churchil Livingstone, Edinburgh UK, 1996, pp 13-31.
12. 2-adrenoreceptors in halothane- anesthetized dogs. Anesthesiology 75: 113-117, 1991.
13. HESS L, DVOŘÁČEK I, SVOBODNÍK J: Anesthesia for Experimental Animals, (in Czech) Avicenum. Prague, 1984, pp 203-210.
14. KAMOHARA Y, ROZGA J, DEMETRIOU AA: Artificial liver: review and Cedars-Sinai experience. J Hepatobiliary Pancreat Surg 5: 273-285, 1998.
15. KAPTANOGLU L, BLEI AT: Current status of liver support systems. Clin Liver Dis 4: 711-729, 2000.
16. KELLY JH, KOUSSAVER T, HE DE: An improved model of acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 15: 329-335, 1992.
17. LARSEN FS, STRAUUSS G, KNUDSEN GM, HERZOG TM, HANSEN BA, SECHER NH: Cerebral perfusion, cardiac output, and arterial pressure in patients with fulminant hepatic failure. Crit Care Med 28: 996-1000, 2000.
18. LEE W: Acute liver failure. N Engl J Med 329: 1862-1872, 1994.
19. MAS A, RODES J: Fulminant hepatic failure. Lancet 349: 1081-1085, 1997.
20. 2-adrenoreceptor agonists: defining role in clinical anesthesia. Anesthesiology 74: 581-605, 1991.
21. MILLER DJ, HICKMAN R, FRATTER R: An animal model of fulminant hepatic failure: A feasibility study. Gastroenterology 71: 109-113, 1976.
22. MUNOZ SJ: Difficult management problems in fulminant hepatic failure. Sem Liver Dis 13: 395-413, 1993.
23. NEUHAUS P, BLUMHARDT G: Extracorporeal liver perfusion: applications of an improved model for experimental studies of the liver. Int J Artif Organs 16: 729-739, 1993.
24. RIORDAN SM, WILIAMS R: Fulminant hepatic failure. Hepatology 4: 25-45, 2000.
25. RYSKA M, KIESLICHOVA E, PANTOFLÍCEK T, RYSKA O, ZAZULA R, SKIBOVÁ J, HÁJEK M: Devascularization surgical model of acute liver failure in minipigs. Eur Surg Res 36: 179-184, 2004.
26. SECHSER A, OSORIO J, FREISE CH, OSORIO RW: Artificial liver support devices for fulminant liver failure. Clin Liver Dis 55: 415-430, 2001.
27. SEIDEL H: Physiologische Mittel- und Grenzwerte. In: Schweinekrankheiten. NEUDORF R, SEIDEL H (eds), VEB Fischer Verlag, Jena, 1972, pp. 29.
28. SHAKIL AO, MAZARIEGOS GV, KRAMER DJ: Fulminant hepatic failure. Surg Clin North Amer 19: 77-108, 1999.
29. SCHARF SM: Hemodynamic and respiratory calculations commonly used in critical care. In: Cardiopulmonary Physiology in Critical Care. SM SCHARF (ed), Marcel Dekker, New York, 1992, pp 429-431.
30. STOCKMANN HB, HIEMSTRA CA, MARQUET RL, IJZERMANS NM: Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg 231: 460-470, 2000.
31. WENDON JA, HARRISON PM, KEAYS R: Cerebral blood flow and metabolism in fulminant hepatic failure. Hepatology 19: 1407-1413, 1994.